(Q44060467)

29 November 2017

title

PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor (English)

1 reference

29 November 2017

7

Dannals RF

1 reference

29 November 2017

Bencherif B

1

1 reference

29 November 2017

Endres CJ

2

1 reference

29 November 2017

Musachio JL

3

1 reference

29 November 2017

Villalobos A

4

1 reference

29 November 2017

Hilton J

5

1 reference

29 November 2017

Scheffel U

6

1 reference

29 November 2017

Williams S

8

1 reference

29 November 2017

Frost JJ

9

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

45

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

1-9

1 reference

Neurotransmitter-related enzymes in senile dementia of the alzheimer type

29 November 2017

cites work

1 reference

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease

21 January 2018

1 reference

Structural correlates of cognition in dementia: quantification and assessment of synapse change.

21 January 2018

1 reference

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

Column-switching HPLC for the analysis of plasma in PET imaging studies.

21 January 2018

1 reference

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease

21 January 2018

1 reference

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

21 January 2018

1 reference

Nitric oxide synthase inhibitors unmask acetylcholine-mediated constriction of cerebral vessels in the in vitro isolated guinea-pig brain.

21 January 2018

1 reference

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

Pyramidal nerve cell loss in Alzheimer's disease

21 January 2018

1 reference

Interaction between cerebrovascular sympathetic, parasympathetic and sensory nerves in blood flow regulation

21 January 2018

1 reference

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

RBC cholinesterase inhibition: a useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?

21 January 2018

1 reference

Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy.

21 January 2018

1 reference

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds

21 January 2018

1 reference

In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers.

21 January 2018

1 reference

The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease

21 January 2018

1 reference

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system

21 January 2018

1 reference

5,7-Dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: A Potent and Centrally-Selective Inhibitor of Acetylcholinesterase

21 January 2018

1 reference

The Disposition of Formaldehyde and Formate Arising from Drug N-Demethylations Dependent on Cytochrome P-450 in Hepatocytes and in Perfused Rat Liver

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SYN.10072

1 reference

29 November 2017

1 reference